Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Einck

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|December 12, 2007
In vitro antimycobacterial activities of capuramycin analoguesVenkata M Reddy, Leo Einck, Carol A Nacy
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 27, 2010
Anti-tuberculosis drug therapy in mice of different inbred strainsBoris V Nikonenko, Leo Einck, Carol A Nacy
Antimicrobial Agents and Chemotherapy|November 25, 2004
Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosisBoris V Nikonenko, Rowena Samala, Leo Einck, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2010
In vitro interactions between new antitubercular drug candidates SQ109 and TMC207Venkata M Reddy, Leo Einck, K Andries, et al.
Plos One|August 13, 2013
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pyloriMorris O Makobongo, Leo Einck, Richard M Peek, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2006
Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitroPing Chen, Jackie Gearhart, Marina Protopopova, et al.
Mbio|March 15, 2012
Generation of a novel nucleic acid-based reporter system to detect phenotypic susceptibility to antibiotics in Mycobacterium tuberculosisMatthew C Mulvey, Katherine A Sacksteder, Leo Einck, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2007
Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugsBoris V Nikonenko, Marina Protopopova, Rowena Samala, et al.
Expert Review of Vaccines|July 9, 2016
Agility in adversity: Vaccines on DemandAnne S De Groot, Leonard Moise, David Olive, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|May 17, 2007
In search of new cures for tuberculosisMarina Protopopova, Elena Bogatcheva, Boris Nikonenko, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|December 12, 2007
In vitro antimycobacterial activities of capuramycin analoguesVenkata M Reddy, Leo Einck, Carol A Nacy
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 27, 2010
Anti-tuberculosis drug therapy in mice of different inbred strainsBoris V Nikonenko, Leo Einck, Carol A Nacy
Antimicrobial Agents and Chemotherapy|November 25, 2004
Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosisBoris V Nikonenko, Rowena Samala, Leo Einck, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2010
In vitro interactions between new antitubercular drug candidates SQ109 and TMC207Venkata M Reddy, Leo Einck, K Andries, et al.
Plos One|August 13, 2013
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pyloriMorris O Makobongo, Leo Einck, Richard M Peek, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2006
Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitroPing Chen, Jackie Gearhart, Marina Protopopova, et al.
Mbio|March 15, 2012
Generation of a novel nucleic acid-based reporter system to detect phenotypic susceptibility to antibiotics in Mycobacterium tuberculosisMatthew C Mulvey, Katherine A Sacksteder, Leo Einck, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2007
Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugsBoris V Nikonenko, Marina Protopopova, Rowena Samala, et al.
Expert Review of Vaccines|July 9, 2016
Agility in adversity: Vaccines on DemandAnne S De Groot, Leonard Moise, David Olive, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|May 17, 2007
In search of new cures for tuberculosisMarina Protopopova, Elena Bogatcheva, Boris Nikonenko, et al.
Pageof 3